MEDIORG — Medicamen Organics Cashflow Statement
0.000.00%
- IN₹398.97m
- IN₹502.33m
- IN₹381.88m
- 33
- 78
- 24
- 41
Annual cashflow statement for Medicamen Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | IAS | IAS | IAS | — | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2.47 | 0.783 | 12.5 | 33.9 | 54.3 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 4.31 | 4.07 | 5.46 | 6.34 | 4.19 |
Other Non-Cash Items | |||||
Changes in Working Capital | -27.5 | -14.3 | -32.2 | -84 | -110 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -12.4 | -0.949 | -6.05 | -36.6 | -45.4 |
Capital Expenditures | — | -6.16 | -2.89 | -3.51 | -24.5 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.478 | 0.217 | 0.098 | 0.134 | 0.948 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.478 | -5.95 | -2.79 | -3.37 | -23.5 |
Financing Cash Flow Items | -4.43 | -4.28 | -5.55 | 5.53 | 76.8 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 12.9 | 2.33 | 9.99 | 40.1 | 105 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.956 | -4.56 | 1.14 | 0.149 | 35.8 |